Patient’s Journey: Experience with mCRPC and the Lutetium (Pluvicto) Shortage
E. David Crawford, MD, interviews Lon and his partner Kacy about Lon’s 5-year treatment experience with advanced prostate cancer.
Read More
Video
OPTIMUM Trial – Current and Emerging Evidence Supporting 29MHz High- Precision, Real-Time Micro-Ultrasound
Preston C. Sprenkle, MD, discusses the OPTIMUM trial examining micro-ultrasound, MRI fusion, and the combination of these in prostate cancer diagnosis.
Read More
NCCN Guidelines for Treatment of Localized Prostate Cancer
Kelvin A. Moses, MD, PhD, FACS, discusses updates to the National Comprehensive Cancer Network (NCCN) guidelines for localized prostate cancer treatment.
Read More
Use of the Cxbladder Monitor Urine Genomics Test for Surveillance of Patients with Non-Muscle-Invasive Bladder Cancer
Daniel Shoskes, MD; John P. Sfakianos, MD; and Sima P. Porten, MD, MPH; discuss the Cxbladder Monitor Test in surveillance of NMIBC patients.
Read More
Bladder Cancer Risk Stratification: Moving from the Old to the New
Joshua J. Meeks, MD, PhD, discusses risk stratification and treatment options for patients with non-muscle-invasive bladder cancer (NMIBC).
Read More